Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Novokhodko A"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Manson, Megan A. *, Zhang, Feng *, Novokhodko, Alexander, Chen, Chun-Yu, Parker, Maura, Loeb, Keith R., Kajimoto, Masaki, Campbell, Carley, Storb, Rainer F., Miao, Carol H. *
Publikováno v:
In Blood Advances 28 June 2022 6(12):3557-3568
Autor:
Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Bruce Zetter, Michael S. Rogers, Diane Joseph-McCarthy, Arijit Chakravarty
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract The rapid emergence and expansion of novel SARS-CoV-2 variants threatens our ability to achieve herd immunity for COVID-19. These novel SARS-CoV-2 variants often harbor multiple point mutations, conferring one or more evolutionarily advantag
Externí odkaz:
https://doaj.org/article/1e588587b1a248438243cf75bb3474be
Autor:
Stoddard, Madison1, Novokhodko, Alexander2, Sarkar, Sharanya3, Van Egeren, Debra4, White, Laura F.5, Hochberg, Natasha S.6, Rogers, Michael S.7,8, Zetter, Bruce7,8, Joseph-McCarthy, Diane9, Chakravarty, Arijit1 arijit@fractaltx.com
Publikováno v:
COVID. Dec2022, Vol. 2 Issue 12, p1689-1709. 21p.
Autor:
Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Bruce Zetter, Michael Rogers, Bradley L Pentelute, Jonathan M Carlson, Mark Hixon, Diane Joseph-McCarthy, Arijit Chakravarty
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0250780 (2021)
The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is the molecular target for many vaccines and antibody-based prophylactics aimed at bringing COVID-19 under control. Such a narrow molecular focus raises the specter of viral immune evasio
Externí odkaz:
https://doaj.org/article/df07e5ae9e2b41f6a400a2d607fc2dec
Autor:
Debra Van Egeren, Madison Stoddard, Alexander Novokhodko, Michael S Rogers, Diane Joseph-McCarthy, Bruce Zetter, Arijit Chakravarty
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0258997 (2021)
The development and deployment of several SARS-CoV-2 vaccines in a little over a year is an unprecedented achievement of modern medicine. The high levels of efficacy against transmission for some of these vaccines makes it feasible to use them to sup
Externí odkaz:
https://doaj.org/article/e511335d15b14ea08376aac679b5be1b
Autor:
Madison Stoddard, Alexander Novokhodko, Sharanya Sarkar, Debra Van Egeren, Laura F. White, Natasha S. Hochberg, Michael S. Rogers, Bruce Zetter, Diane Joseph-McCarthy, Arijit Chakravarty
Publikováno v:
COVID; Volume 2; Issue 12; Pages: 1689-1709
We have entered a new phase of the ongoing COVID-19 pandemic, as the strategy of relying solely on the current SARS-CoV-2 vaccines to bring the pandemic to an end has become infeasible. In response, public-health authorities in many countries have ad
Autor:
Van Egeren, Debra1,2,3 (AUTHOR), Novokhodko, Alexander4 (AUTHOR), Stoddard, Madison5 (AUTHOR), Tran, Uyen5 (AUTHOR), Zetter, Bruce1,3 (AUTHOR), Rogers, Michael S.1,3 (AUTHOR), Joseph-McCarthy, Diane6 (AUTHOR), Chakravarty, Arijit5 (AUTHOR) arijit@fractaltx.com
Publikováno v:
Scientific Reports. 11/19/2021, Vol. 11 Issue 1, p1-9. 9p.
Autor:
Van Egeren, Debra1,2,3 (AUTHOR), Novokhodko, Alexander4 (AUTHOR), Stoddard, Madison5 (AUTHOR), Tran, Uyen5 (AUTHOR), Zetter, Bruce6 (AUTHOR), Rogers, Michael6 (AUTHOR), Pentelute, Bradley L.7 (AUTHOR), Carlson, Jonathan M.8 (AUTHOR), Hixon, Mark9 (AUTHOR), Joseph-McCarthy, Diane10 (AUTHOR), Chakravarty, Arijit5 (AUTHOR) arijit@fractal.tx
Publikováno v:
PLoS ONE. 4/28/2021, Vol. 16 Issue 4, p1-17. 17p.
Publikováno v:
Cryobiology. 109:59